STTCOMP NTI FA LONG
MC $96.32M
Cash $14.5M
NTI Today Announced:
Neurotech Phase II/III Autism Trial Successfully Meets Primary Endpoint
https://www.investi.com.au/api/announcements/nti/3e87a498-65a.pdf
And
Neurotech Reports Positive Top-Line Phase I/II Rett Syndrome Clinical Trial Results
https://www.investi.com.au/api/announcements/nti/6b645e01-525.pdf
To have 2 sets of good results is excellent news for any company.
Completion of Phase II Trial Results is often the stage companies make Partnerships,
Or are complete Take-Overs are made by Big Pharma Companies.
The fact that one of these was a Phase II/III is even better.
The stage after Phase III is FDA Approval,
After which sales of the product can begin.
The Autism Market is a very large and growing market.
The global autism spectrum disorder therapeutics market is projected to grow from $2.01 billion in 2023 to $3.42 billion by 2030, at a CAGR of 7.9%
https://www.fortunebusinessinsights...-spectrum-disorder-therapeutics-market-101207
The global Autism Spectrum Disorders market was valued at $27.3 billion in 2021,
and is projected to reach $43.2 billion by 2031
A Product that can treat it would be valued at many Billions of Dollars.
NTI has shown excellent results and has completed Phase II/ III Human Trials,
Which is the Ideal Time for a Big Pharma Co. to make a Partnership or takeover offer.
NTI has an MC of $96 Million,
Giving a very Significant potential upside,
As well as that this stage is the usual time for Partnerships,
And Outright Take-Over Offers to be made.
Seems like a good time for being tipped in the STT Comp !!!!
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 15 Apr
STTCOMP NTI FA LONG MC $96.32M Cash $14.5M NTI Today Announced:...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)